Filing Details

Accession Number:
0001144204-18-050778
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-09-25 19:00:57
Reporting Period:
2018-09-21
Accepted Time:
2018-09-25 19:00:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
910267 Titan Pharmaceuticals Inc TTNP Biological Products, (No Disgnostic Substances) (2836) 943171940
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1379888 A Joseph Akers 102 W. Glenhaven Drive
Phoenix AZ 85045
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-09-21 200,000 $0.25 213,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrants Acquisiton 2018-09-21 200,000 $0.00 200,000 $0.25
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
200,000 2018-09-25 2023-09-25 No 4 A Direct